GUO ZHIQIANG
No ORCID on file
· 14 papers in corpus
· active 2009
Frequent coauthors
- CHEN CHEN 14
- CHEN YONGSHENG 14
- DWIGHT WESLEY J 14
- HUANG CHARLES Q 14
- TUCCI FABIO C 14
- WU DONGPEI 14
- WADE WARREN 14
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…
2009
Disclosed are compounds of the following formula, wherein the substituents are as defined in the specification. The compounds are GnRH receptor antagonists useful in the treatment of a variety of sex-hormone related conditions in both men a…